Wafik El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared a post on LinkedIn:
“For nearly three decades since my lab reported the discovery of Death Receptor 5, the El Deiry Lab has studied the TRAIL pathway that engages a powerful cancer self-destruct apoptosis mechanism through the innate immune system and natural killer cells.”
More posts featuring Wafik S. El-Deiry.